Fisher Asset Management
AUPH icon

Fisher Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Fisher Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,750
Closed -$185K – 827
2020
Q1 		$185K Buy
+12,750
New +$225K ﹤0.01% 736

Other funds holding AUPH

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Fisher Asset Management's AUPH Position: Q2 2020 in Review

Fisher Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2020, closing a stake of 12,750 shares — an estimated $185K sold.

Fisher Asset Management first reported a position in AUPH in Q1 2020 and held it in 1 quarter. The position peaked at $185K in Q1 2020. 132 funds tracked by Wall St. Rank hold AUPH as of Q2 2020.

  • Fisher Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Fisher Asset Management sold 12,750 Aurinia Pharmaceuticals shares in Q2 2020, an estimated $185K.
  • Fisher Asset Management first reported a position in Aurinia Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Fisher Asset Management's Aurinia Pharmaceuticals position peaked at $185K in Q1 2020.
  • 132 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2020.

Based on Fisher Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.